Cargando…

Efficacy and Safety of Different Dosages of Praziquantel for the Treatment of Schistosoma Japonicum: A Systematic Review and Meta-Analysis

BACKGROUND: Praziquantel, an antischistosomal compound, is used as first-line drug for chemotherapy of Schistosoma japonicum since 1984. In this article, we conducted a systematic review and mete-analysis to evaluate the efficacy and safety of different dosages of praziquantel (PZQ) for treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Damin, Zhang, Si, Wu, Julong, Wang, Xun, Wang, Meng, Lu, Xiaoling, Chen, Huiyu, Wang, Qian, Ma, Xingming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270676/ https://www.ncbi.nlm.nih.gov/pubmed/25558390 http://dx.doi.org/10.5812/ircmj.9600

Ejemplares similares

Synthesis and SAR Studies of Praziquantel Derivatives with Activity against Schistosoma japonicum
por: Wang, Wen-Long, et al.
Publicado: (2013)

New Insight into the Antifibrotic Effects of Praziquantel on Mice in Infection with Schistosoma japonicum
por: Liang, Yue-Jin, et al.
Publicado: (2011)

Expression of Septin4 in Schistosoma japonicum-infected mouse livers after praziquantel treatment
por: Zhu, Dandan, et al.
Publicado: (2015)

Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum
por: Bustinduy, Amaya L., et al.
Publicado: (2020)

In vivo efficiency of praziquantel treatment of single-sex Schistosoma japonicum aged three months old in mice
por: Wang, Ning, et al.
Publicado: (2022)

In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum
por: Wang, Xiaoli, et al.
Publicado: (2019)

Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies
por: Xiao, Shu-Hua, et al.
Publicado: (2018)

Synergistic effect of combination chemotherapy with praziquantel and DW-3-15 for Schistosoma japonicum in vitro and in vivo
por: Yang, Zi-Yin, et al.
Publicado: (2021)

MicroRNA-21 Mediates the Inhibiting Effect of Praziquantel on NLRP3 Inflammasome in Schistosoma japonicum Infection
por: Kong, Delong, et al.
Publicado: (2020)

Praziquantel treatment after Schistosoma japonicum infection maintains hepatic insulin sensitivity and improves glucose metabolism in mice
por: Luo, Xiaofeng, et al.
Publicado: (2017)

A Polysaccharide from Amusium Pleuronectes Combined with Praziquantel Treatment Ameliorates Hepatic Fibrosis in Schistosoma Japonicum-Infected Mice
por: Tang, Xiaoniu, et al.
Publicado: (2018)

Efficacy and safety of praziquantel against Schistosoma haematobium in the Ikata-Likoko area of southwest Cameroon
por: Ebai, Calvin Bisong, et al.
Publicado: (2017)

Efficacy and Safety of Praziquantel for Treatment of Schistosoma mansoni Infection among School Children in Tanzania
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2019)

Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
por: Amer, Eglal I., et al.
Publicado: (2022)

Efficacy and Safety of Praziquantel in Preschool-Aged Children in an Area Co-Endemic for Schistosoma mansoni and S. haematobium
por: Coulibaly, Jean T., et al.
Publicado: (2012)

Functional characterisation of Schistosoma japonicum acetylcholinesterase
por: You, Hong, et al.
Publicado: (2016)

Effect of maternal praziquantel treatment for Schistosoma japonicum infection on the offspring susceptibility and immunologic response to infection at age six, a cohort study
por: Colt, Susannah, et al.
Publicado: (2021)

Efficacy of Praziquantel against Schistosoma haematobium in Dulshatalo village, western Ethiopia
por: Mekonnen, Asaye, et al.
Publicado: (2013)

Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial
por: Barda, Beatrice, et al.
Publicado: (2016)

Schistosoma haematobium Treatment in 1–5 Year Old Children: Safety and Efficacy of the Antihelminthic Drug Praziquantel
por: Mutapi, Francisca, et al.
Publicado: (2011)

Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya
por: Kimani, Bridget W., et al.
Publicado: (2018)

THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO PRAZIQUANTEL
por: MENDONÇA, Adriana Maria B., et al.
Publicado: (2016)

Effect of Praziquantel on Schistosoma mekongi Proteome and Phosphoproteome
por: Chienwichai, Peerut, et al.
Publicado: (2020)

An improved genome assembly of the fluke Schistosoma japonicum
por: Luo, Fang, et al.
Publicado: (2019)

Control Efficacy of Annual Community-Wide Treatment against Schistosoma japonicum in China: A Meta-Analysis
por: Su, Jing, et al.
Publicado: (2013)

Praziquantel, Mefloquine-Praziquantel, and Mefloquine-Artesunate-Praziquantel against Schistosoma haematobium: A Randomized, Exploratory, Open-Label Trial
por: Keiser, Jennifer, et al.
Publicado: (2014)

A metabotropic glutamate receptor affects the growth and development of Schistosoma japonicum
por: Wang, Xiaoling, et al.
Publicado: (2022)

Jejunal Ulcer Caused by Schistosoma japonicum
por: Rivadeneira, Daniela Jaqueline, et al.
Publicado: (2019)

Schistosoma japonicum Associated With Colorectal Cancer
por: Almoghrabi, Anas, et al.
Publicado: (2021)

Efficacy of Artesunate + Sulfamethoxypyrazine/Pyrimethamine versus Praziquantel in the Treatment of Schistosoma haematobium in Children
por: Sissoko, Mahamadou S., et al.
Publicado: (2009)

Non-equilibrium plasma prevention of Schistosoma japonicum transmission
por: Wang, Xing-Quan, et al.
Publicado: (2016)

Exploring molecular variation in Schistosoma japonicum in China
por: Young, Neil D., et al.
Publicado: (2015)

Identification and characterization of microRNAs and endogenous siRNAs in Schistosoma japonicum
por: Hao, Lili, et al.
Publicado: (2010)

Profiles of Small Non-Coding RNAs in Schistosoma japonicum during Development
por: Cai, Pengfei, et al.
Publicado: (2011)

Protein undernutrition reduces the efficacy of praziquantel in a murine model of Schistosoma mansoni infection
por: Kadji Fassi, Joseph Bertin, et al.
Publicado: (2022)

Cloning and Characterisation of Schistosoma japonicum Insulin Receptors
por: You, Hong, et al.
Publicado: (2010)

Schistosoma japonicum infection induces macrophage polarization
por: Xu, Jingwei, et al.
Publicado: (2014)

First case report of Schistosoma japonicum in Nepal
por: Bajracharya, Dipendra, et al.
Publicado: (2020)

Experimental Schistosoma japonicum-induced pulmonary hypertension
por: Kassa, Biruk, et al.
Publicado: (2022)

Therapeutic efficacy of Schistosoma japonicum cystatin on sepsis-induced cardiomyopathy in a mouse model
por: Gao, Shifang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5i0b8ovu9jgkt0spn9k7g4brci